We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$5.12B
AUM Growth
+$72.4M
Cap. Flow
-$282M
Cap. Flow %
-5.52%
Top 10 Hldgs %
35.15%
Holding
73
New
9
Increased
23
Reduced
23
Closed
13

Sector Composition

Rank Sector Weight
1 Communication Services 19.91%
2 Technology 19.02%
3 Healthcare 15.55%
4 Financials 14.75%
5 Consumer Discretionary 11.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
1
Baidu
BIDU
$35.8B
$215M 4.21%
944,747
-208,300
-18% -$47.7M
ICE icon
2
Intercontinental Exchange
ICE
$82.4B
$204M 3.98%
4,646,850
-710,200
-13% -$30.4M
CELG
3
DELISTED
Celgene Corp
CELG
$196M 3.83%
1,751,500
-208,000
-11% -$21.9M
MA icon
4
Mastercard
MA
$477B
$186M 3.64%
2,162,980
+191,500
+10% +$15.6M
AAPL icon
5
Apple
AAPL
$4.89T
$175M 3.42%
6,339,868
+176,000
+3% +$4.79M
V icon
6
Visa
V
$677B
$173M 3.38%
2,639,376
+1,190,000
+82% +$71.6M
QCOM icon
7
Qualcomm
QCOM
$176B
$168M 3.28%
2,257,755
-404,720
-15% -$29.6M
DG icon
8
Dollar General
DG
$25.9B
$167M 3.26%
2,360,000
+1,810,000
+329% +$118M
COST icon
9
Costco
COST
$415B
$160M 3.13%
1,130,692
+20,000
+2% +$2.72M
TRIP icon
10
TripAdvisor
TRIP
$1.59B
$155M 3.02%
2,071,152
+182,480
+10% +$14.2M
PARA
11
DELISTED
Paramount Global Class B
PARA
$154M 3.01%
2,779,517
+141,300
+5% +$7.53M
CMCSA icon
12
Comcast
CMCSA
$79.1B
$153M 2.99%
5,279,880
-1,362,000
-21% -$37.3M
DLTR icon
13
Dollar Tree
DLTR
$23.1B
$151M 2.94%
2,138,901
+360,000
+20% +$22.7M
COR icon
14
Cencora
COR
$60.3B
$146M 2.85%
1,616,450
-427,500
-21% -$36.7M
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
$135M 2.64%
730,570
-248,000
-25% -$46M
XLNX
16
DELISTED
Xilinx Inc
XLNX
$130M 2.55%
3,010,244
+418,000
+16% +$18.1M
LRCX icon
17
Lam Research
LRCX
$382B
$124M 2.43%
15,687,300
+860,000
+6% +$6.67M
SNPS icon
18
Synopsys
SNPS
$71.5B
$123M 2.4%
2,821,605
+728,000
+35% +$30.2M
TFCF
19
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$118M 2.31%
3,211,593
-1,425,000
-31% -$48.6M
JWN
20
DELISTED
Nordstrom
JWN
$117M 2.29%
1,475,274
+93,000
+7% +$6.83M
PINC
21
DELISTED
Premier
PINC
$107M 2.09%
3,194,145
+60,600
+2% +$1.98M
VIPS icon
22
Vipshop
VIPS
$6.84B
$99.9M 1.95%
5,113,060
-1,400,000
-21% -$29.5M
AMG icon
23
Affiliated Managers Group
AMG
$9.46B
$96.7M 1.89%
455,530
+40,000
+10% +$7.95M
BFH icon
24
Bread Financial
BFH
$4.21B
$95.3M 1.86%
417,387
+92,534
+28% +$20.3M
NWS icon
25
News Corp Class B
NWS
$16.4B
$93M 1.82%
6,167,994
-1,992,356
-24% -$29.8M

Similar funds

Alkeon Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Alkeon Capital Management held 73 positions worth $5.12B, up 1.4% from $5.05B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Alkeon Capital Management withdrew a net $282M in Q4 2014, closing 13 positions and reducing 23 holdings. Its most notable exit was Gilead Sciences, an estimated $101M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 20% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Alkeon Capital Management opened a new position in Walgreens Boots Alliance worth $84.6M.

  • Alkeon Capital Management's largest Q4 2014 buy was Walgreens Boots Alliance: 1,110,000 shares worth $84.6M.
  • Alkeon Capital Management added most to Dollar General in Q4 2014, an estimated $118M increase.
  • Alkeon Capital Management's biggest Q4 2014 reduction was BioMarin Pharmaceuticals, cutting an estimated $54.6M.
  • Alkeon Capital Management fully exited Gilead Sciences in Q4 2014, selling an estimated $101M.
  • Alkeon Capital Management's ten largest holdings make up 35% of its $5.12B portfolio in Q4 2014.
  • Alkeon Capital Management opened 9 new positions and closed 13 in Q4 2014.
  • Alkeon Capital Management's portfolio value rose 1.4% quarter-over-quarter to $5.12B.

Based on Alkeon Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.